Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2010
04/08/2010DE102007021043B4 Alpha-Form von Imatinib Mesylat und Verfahren zu seiner Herstellung Alpha-form of imatinib mesylate and a process for its preparation
04/08/2010DE102007010077B4 [1,3]-Dioxane zur Modulation von GABAa-Rezeptoren [1,3] -Dioxane for modulation of GABAa receptors
04/08/2010DE102005004643B4 Antivirale Kombinationen sowie ihre Verwendung Antiviral combinations and their use
04/08/2010CA2742550A1 4-morpholino-pyrido[3,2-d]pyrimidines
04/08/2010CA2742389A1 Topical treatment of skin infection
04/08/2010CA2740477A1 Bile acids and biguanides as protease inhibitors for preserving the integrity of peptides in the gut
04/08/2010CA2740342A1 Pharmaceutical composition for modified release
04/08/2010CA2739513A1 7-piperidinoalkyl-3,4-dihydroquinolone derivative
04/08/2010CA2739505A1 Anti-xdr-tb agent, anti-mdr-tb agent, and combined anti-tuberculosis agent
04/08/2010CA2739503A1 Novel nitrogenous heterocyclic compounds, preparation thereof and use thereof as antibacterial medicaments
04/08/2010CA2739499A1 Improved nanoparticulate compositions of poorly soluble compounds
04/08/2010CA2739463A1 Methods and compositions for treatment of acute heart failure
04/08/2010CA2739436A1 Methods of treating hepatic encephalopathy
04/08/2010CA2739376A1 Stabilized composition for treating psoriasis
04/08/2010CA2739322A1 Compounds for inflammation and immune-related uses
04/08/2010CA2739321A1 Compounds for inflammation and immune-related uses
04/08/2010CA2739303A1 Compounds for inflammation and immune-related uses
04/08/2010CA2739263A1 Tryptophan hydroxylase inhibitors and methods of their use
04/08/2010CA2739207A1 Imaging neuroinflammation
04/08/2010CA2739181A1 Implantable device for the delivery of risperidone and methods of use thereof
04/08/2010CA2739178A1 Long term drug delivery devices with polyurethane-based polymers and their manufacture
04/08/2010CA2738985A1 Therapeutic agent for hepatitis c
04/08/2010CA2738928A1 Treatment of hepatitis c infection with metalloporphyrins
04/08/2010CA2738925A1 Hematopoietic protection against chemotherapeutic compounds using selective cyclin-dependent kinase 4/6 inhibitors
04/08/2010CA2738912A1 Pharmaceutical composition for oral administration
04/08/2010CA2738868A1 Smoothened antagonism for the treatment of hedgehog pathway-related disorders
04/08/2010CA2738828A1 Novel compounds
04/08/2010CA2738827A1 P38 mapk kinase inhibitors
04/08/2010CA2738799A1 Antioxidant compounds and methods of their use
04/08/2010CA2738768A1 2-acylaminopropoanol-type glucosylceramide synthase inhibitors
04/08/2010CA2738663A1 Spiro-imidazolone derivatives as glucagon receptor antagonists
04/08/2010CA2738657A1 Cgrp receptor antagonists
04/08/2010CA2738650A1 Fused diimidazodiazepine compounds and methods of use and manufacture thereof
04/08/2010CA2738563A1 8-substituted isoquinoline derivatives and the use thereof
04/08/2010CA2738520A1 Janus kinase inhibitors for treatment of dry eye and other eye related diseases
04/08/2010CA2738496A1 Compositions for proliferation of cells and related methods
04/08/2010CA2738449A1 Novel ezetimibe formulations
04/08/2010CA2738348A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
04/08/2010CA2738314A1 1,2-benzisothiazolinone and isoindolinone derivatives
04/08/2010CA2738313A1 Viral and fungal inhibitors
04/08/2010CA2738256A1 A group of amino substituted benzoyl derivatives and their preparation and their use
04/08/2010CA2738150A1 Novel fused aminodihydrothiazine derivative
04/08/2010CA2738041A1 Oxopiperidinyl and pyranyl sulfonamides as ampa potentiators
04/08/2010CA2738019A1 Sirt4 and uses thereof
04/08/2010CA2737522A1 Guanylhydrazones for treatment of postoperative intestinal inflammation
04/08/2010CA2737480A1 Novel compounds as calcium channel blockers
04/08/2010CA2737434A1 Isoquinolinone derivatives
04/08/2010CA2737267A1 Selective glycosidase inhibitors and uses thereof
04/08/2010CA2737263A1 Mucomimetic compositions and uses therefore
04/08/2010CA2737217A1 Heterocyclic jak kinase inhibitors
04/08/2010CA2736263A1 Systemic treatment of blood-sucking and blood-consuming parasites by oral administration of a parasiticidal agent
04/08/2010CA2736258A1 Tricyclic carbamate jak inhibitors
04/08/2010CA2736102A1 Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
04/08/2010CA2735932A1 Imidazo[1,5]naphthyridine compounds, their pharmaceutical use and compositions
04/08/2010CA2733265A1 Transdermal extended-delivery donepezil compositions and methods for using the same
04/08/2010CA2732613A1 Oral formulation
04/08/2010CA2704448A1 Amorphous compositions of sunitinib base and l-malic acid
04/07/2010EP2172560A2 stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents
04/07/2010EP2172559A1 Screening method
04/07/2010EP2172472A2 Aminophosphonic acid derivative, salt thereof and modulator of S1P receptor
04/07/2010EP2172469A1 Diazabicyclic aryl derivatives as cholinergic receptor modulators
04/07/2010EP2172468A1 Benzimidazolone compounds
04/07/2010EP2172461A1 Di(arylamino)aryl compound
04/07/2010EP2172460A1 Compositions useful as inhibitors of JAK and other protein kinases
04/07/2010EP2172458A1 Pyrazolone derivative
04/07/2010EP2172457A2 Fredericamycin derivatives
04/07/2010EP2172454A1 Benzimidazole derivative
04/07/2010EP2172453A1 COMPOUND HAVING 11 ß-HSD1 INHIBITORY ACTIVITY
04/07/2010EP2172452A1 Preparation of crystalline atorvastatin magnesium
04/07/2010EP2172451A2 Derivatives of 1-{[1,5-bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl]methyl}-4-methylpiperazine, synthesis and use thereof
04/07/2010EP2172450A1 Novel malonic acid sulfonamide derivative and pharmaceutical use thereof
04/07/2010EP2172449A2 Process for the purification of Anastrazole
04/07/2010EP2172447A1 Amide compound
04/07/2010EP2172444A1 Pet probe having alkoxy group substituted by fluorine and hydroxy group
04/07/2010EP2172246A2 Methods for Alzheimer's disease treatment and cognitive enhancement
04/07/2010EP2172229A1 Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles
04/07/2010EP2172226A1 Method of fixing and expressing physiologically active substance
04/07/2010EP2172225A1 Sealmess capsule
04/07/2010EP2172223A1 Composition containing physiologically active substance
04/07/2010EP2172222A2 Novel BLT2-mediated disease, BLT2-binding agent and compound
04/07/2010EP2172221A1 Composition for ophthalmic disease associated with hypoxia or ischemia
04/07/2010EP2172220A1 Methods of diagnosing and treating pre-eclampsia or eclampsia
04/07/2010EP2172219A1 Anti-cancer agent comprising an iNKT ligand and anti-PD-1 antibody or anti-PD-L1 antibody
04/07/2010EP2172214A2 Chlamydia antigens and corresponding DNA fragments and uses thereof
04/07/2010EP2172204A1 Methods of treating syndrome X with apliphatic polyamines
04/07/2010EP2172203A1 Pharmaceutical composition for the treatment of gastrointestinal irritation disorders
04/07/2010EP2172202A1 Prostaglandin derivative-containing aqueous liquid agent
04/07/2010EP2172201A1 Pharmaceutical composition for amelioration of lower urinary tract symptom associated with prostatomegaly
04/07/2010EP2172200A1 Coated preparation
04/07/2010EP2172199A1 Sustained release tablet comprising pramipexole
04/07/2010EP2172198A1 p27 PROTEIN INDUCER
04/07/2010EP2172197A1 Octanoic acid derivative to treat fibromyalgia and other pains
04/07/2010EP2172196A1 Composition containing coenzyme q10
04/07/2010EP2172195A1 Cholesterol-control agent
04/07/2010EP2172194A1 Transdermal drug delivery system for liquid active ingredient
04/07/2010EP2172193A1 Improved nanoparticulate compositions of poorly soluble compounds
04/07/2010EP2172192A1 Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder of granular material, and process and tooling for producing it
04/07/2010EP2172106A1 Allantoin-containing skin cream
04/07/2010EP2171448A2 Methods and agents for inhibiting tumor growth by targeting the ssdna replication intermediate of tumor stem cells
04/07/2010EP2171060A2 Superagonistic anti-cd28 antibody
1 ... 2317 2318 2319 2320 2321 2322 2323 2324 2325 2326 2327 2328 2329 2330 2331 2332 2333 2334 2335 2336 2337 ... 7860